Bactiguard Holding AB
STO:BACTI B

Watchlist Manager
Bactiguard Holding AB Logo
Bactiguard Holding AB
STO:BACTI B
Watchlist
Price: 16.75 SEK -3.74% Market Closed
Market Cap: kr519.9m

Relative Value

The Relative Value of one BACTI B stock under the Base Case scenario is 26.53 SEK. Compared to the current market price of 16.75 SEK, Bactiguard Holding AB is Undervalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BACTI B Relative Value
Base Case
26.53 SEK
Undervaluation 37%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

BACTI B Competitors Multiples
Bactiguard Holding AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Bactiguard Holding AB
STO:BACTI B
519.9m SEK 2.3 -66.3 -187.8 -187.8
US
Medline Inc
NASDAQ:MDLN
62.4B USD 0 0 0 0
JP
Hoya Corp
TSE:7741
9.5T JPY 10.4 38 27.5 33
CH
Alcon AG
SIX:ALC
32.3B CHF 4.1 39.9 16.6 32.3
DK
Coloplast A/S
CSE:COLO B
109.3B DKK 3.9 27.6 14.3 17
US
Align Technology Inc
NASDAQ:ALGN
13.6B USD 3.4 33.2 17.7 22.9
UK
ConvaTec Group PLC
LSE:CTEC
4.9B GBP 2.7 38 15 25.6
CA
Bausch + Lomb Corp
NYSE:BLCO
6.3B USD 1.2 -17.6 18.1 58.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
41.3B CNY 9.1 25 22.6 22.6
JP
Asahi Intecc Co Ltd
TSE:7747
887B JPY 6.8 50.1 23.7 32.2
CH
Ypsomed Holding AG
SIX:YPSN
3.8B CHF 4.8 19.5 12.6 17.1
P/E Multiple
Earnings Growth PEG
SE
Bactiguard Holding AB
STO:BACTI B
Average P/E: 33.9
Negative Multiple: -66.3
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
38
13%
2.9
CH
Alcon AG
SIX:ALC
39.9
25%
1.6
DK
Coloplast A/S
CSE:COLO B
27.6
22%
1.3
US
Align Technology Inc
NASDAQ:ALGN
33.2
34%
1
UK
ConvaTec Group PLC
LSE:CTEC
38
41%
0.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.6 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25
9%
2.8
JP
A
Asahi Intecc Co Ltd
TSE:7747
50.1
37%
1.4
CH
Ypsomed Holding AG
SIX:YPSN
19.5
32%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
Bactiguard Holding AB
STO:BACTI B
Average EV/EBITDA: 18.7
Negative Multiple: -187.8
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
27.5
12%
2.3
CH
Alcon AG
SIX:ALC
16.6
8%
2.1
DK
Coloplast A/S
CSE:COLO B
14.3
6%
2.4
US
Align Technology Inc
NASDAQ:ALGN
17.7
20%
0.9
UK
ConvaTec Group PLC
LSE:CTEC
15
13%
1.2
CA
Bausch + Lomb Corp
NYSE:BLCO
18.1
29%
0.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
22.6
13%
1.7
JP
A
Asahi Intecc Co Ltd
TSE:7747
23.7
11%
2.2
CH
Ypsomed Holding AG
SIX:YPSN
12.6
21%
0.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
Bactiguard Holding AB
STO:BACTI B
Average EV/EBIT: 29
Negative Multiple: -187.8
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
33
N/A N/A
CH
Alcon AG
SIX:ALC
32.3
22%
1.5
DK
Coloplast A/S
CSE:COLO B
17
7%
2.4
US
Align Technology Inc
NASDAQ:ALGN
22.9
24%
1
UK
ConvaTec Group PLC
LSE:CTEC
25.6
33%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
58.5
74%
0.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
22.6
11%
2.1
JP
A
Asahi Intecc Co Ltd
TSE:7747
32.2
N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
17.1
29%
0.6
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett